{"id":"https://openalex.org/W2944822648","doi":"https://doi.org/10.1182/blood.v130.suppl_1.4512.4512","title":"Final Analysis of the Phase I/II Study of CC-486 (Oral Azacitidine) Maintenance Therapy after Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)","display_name":"Final Analysis of the Phase I/II Study of CC-486 (Oral Azacitidine) Maintenance Therapy after Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W2944822648","doi":"https://doi.org/10.1182/blood.v130.suppl_1.4512.4512","mag":"2944822648"},"language":"en","primary_location":{"id":"mag:2944822648","doi":"https://doi.org/10.1182/blood.v130.suppl_1.4512.4512","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/4512/72418/Final-Analysis-of-the-Phase-I-II-Study-of-CC-486","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034264716","display_name":"Marcos J. G. De Lima","orcid":"https://orcid.org/0000-0002-8568-4522","observed_orcids":["https://orcid.org/0000-0002-8568-4522"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210119077","display_name":"University Hospitals Seidman Cancer Center","ror":"https://ror.org/02kb97560","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210119077"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcos de Lima","raw_affiliation_strings":["Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH","Case Western Reserve University, Cleveland, OH"],"raw_orcid":"https://orcid.org/0000-0002-8568-4522","affiliations":[{"raw_affiliation_string":"Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I4210119077"]},{"raw_affiliation_string":"Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085076031","display_name":"Bet\u00fcl Oran","orcid":"https://orcid.org/0000-0003-1264-5968","observed_orcids":["https://orcid.org/0000-0003-1264-5968"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bet\u00fcl Oran","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":"https://orcid.org/0000-0003-1264-5968","affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048913229","display_name":"Richard E. Champlin","orcid":"https://orcid.org/0000-0002-4314-5037","observed_orcids":["https://orcid.org/0000-0002-4314-5037"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E. Champlin","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":"https://orcid.org/0000-0002-4314-5037","affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058746837","display_name":"Esperanza Bouza Papadopoulos","orcid":"https://orcid.org/0000-0001-6066-1861","observed_orcids":["https://orcid.org/0000-0001-6066-1861"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Esperanza B. Papadopoulos","raw_affiliation_strings":["Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":"https://orcid.org/0000-0001-6066-1861","affiliations":[{"raw_affiliation_string":"Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070096873","display_name":"Sergio  A. Giralt","orcid":"https://orcid.org/0000-0003-1944-5053","observed_orcids":["https://orcid.org/0000-0003-1944-5053"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergio Giralt","raw_affiliation_strings":["Department of Medicine Memorial Sloan Kettering Cancer Center New York NY"],"raw_orcid":"https://orcid.org/0000-0003-1944-5053","affiliations":[{"raw_affiliation_string":"Department of Medicine Memorial Sloan Kettering Cancer Center New York NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart L. Scott","raw_affiliation_strings":["Transplantation Biology, Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":"https://orcid.org/0000-0001-9620-7839","affiliations":[{"raw_affiliation_string":"Transplantation Biology, Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064150576","display_name":"Basem Magdy William","orcid":"https://orcid.org/0000-0001-8090-4605","observed_orcids":["https://orcid.org/0000-0001-8090-4605"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Basem M. William","raw_affiliation_strings":["Division of Hematology, The Ohio State University Comprehensive Cancer Center- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH"],"raw_orcid":"https://orcid.org/0000-0001-8090-4605","affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University Comprehensive Cancer Center- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003299911","display_name":"Joel Hetzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Hetzer","raw_affiliation_strings":["Celgene Corporation, Summit, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ;","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046317110","display_name":"Becky Hubbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Becky Hubbell","raw_affiliation_strings":["Celgene Corporation, Summit, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ;","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111658759","display_name":"Barry Skikne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry Skikne","raw_affiliation_strings":["Celgene Corporation, Summit, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ;","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076984999","display_name":"Charles Craddock","orcid":"https://orcid.org/0000-0001-5041-6678","observed_orcids":["https://orcid.org/0000-0001-5041-6678"]},"institutions":[{"id":"https://openalex.org/I2799307867","display_name":"Queen Elizabeth Hospital Birmingham","ror":"https://ror.org/048emj907","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049","https://openalex.org/I2799307867"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charles Craddock","raw_affiliation_strings":["Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-5041-6678","affiliations":[{"raw_affiliation_string":"Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham United Kingdom","institution_ids":["https://openalex.org/I2799307867"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.6334,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.73242949,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"130","issue":null,"first_page":"4512","last_page":"4512"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.7480000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.7480000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.24120000004768372,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cc-486","display_name":"CC-486","score":0.8309999704360962},{"id":"https://openalex.org/keywords/oral-azacitidine","display_name":"oral azacitidine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9750000238418579},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9940000176429749},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":1.0},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.7450000047683716},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8289999961853027},{"id":"https://openalex.org/keywords/epigenetic-therapy","display_name":"epigenetic therapy","score":0.7419999837875366},{"id":"https://openalex.org/keywords/dose-finding","display_name":"dose-finding","score":0.5839999914169312},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7429999709129333},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.6710000038146973},{"id":"https://openalex.org/keywords/treg-reconstitution","display_name":"Treg reconstitution","score":0.6389999985694885},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.7607662677764893},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7382609248161316},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.6145467162132263},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.594031572341919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5311347842216492},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.4959605634212494},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.481767863035202},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.44086769223213196},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4403284788131714},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.43629294633865356},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.43182799220085144},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.41476622223854065},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.3789554536342621},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34717047214508057},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.24221807718276978},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.17426049709320068},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.16797783970832825},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09513083100318909},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2944822648","doi":"https://doi.org/10.1182/blood.v130.suppl_1.4512.4512","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/4512/72418/Final-Analysis-of-the-Phase-I-II-Study-of-CC-486","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2808807711","https://openalex.org/W775166252","https://openalex.org/W2469723064","https://openalex.org/W2593191135","https://openalex.org/W2535838980","https://openalex.org/W4206015272","https://openalex.org/W2884246240","https://openalex.org/W2562266793","https://openalex.org/W7204723125","https://openalex.org/W2979941814"],"abstract_inverted_index":{"Abstract":[0],"Background:":[3],"Most":[4],"relapses":[5,468],"occur":[6],"within":[7,470,478],"1":[8,283,316,406,471],"year":[9,472],"post-transplant":[10,90,682],"and":[11,29,53,94,117,141,157,160,187,220,226,247,251,257,301,315,405,486,513,549,555,558,564,575,603,605,627,647,650,701,797],"relapse":[12,462,626,691],"is":[13,125],"the":[14,100,146,149,154,239,290,334,351,376,423,442,479,508,517,523,547,656,679,687,703,713],"major":[15],"cause":[16],"of":[17,48,80,99,121,130,148,163,261,324,350,354,375,414,419,428,437,457,473,500,625,636,689,712,774,822,840],"treatment":[18],"(Tx)":[19],"failure":[20],"after":[21,167,236],"allo-SCT":[22,175],"for":[23,109,176,274,347,359,490,505,671,697],"patients":[24],"(pts)":[25],"with":[26,115,137,180,195,299,304,622,632,678],"high-risk":[27],"AML":[28,93,305,388,420,698],"MDS.":[30],"Novel":[31],"therapeutic":[32],"strategies":[33],"are":[34,119,676],"urgently":[35],"required.":[36],"The":[37,326,425,595,661],"DNA":[38,143],"methyltransferase":[39],"inhibitor,":[40],"azacitidine":[41],"(AZA),":[42],"was":[43,231,271,330,341,362,432,493,529,537,620],"shown":[44,67],"to":[45,59,68,203,232,272,343,387,411],"increase":[46,608],"expression":[47],"epigenetically":[49],"silenced":[50],"leukemia":[51],"antigens":[52,61],"induce":[54],"a":[55,126,190,399,633],"CD8+":[56],"T-cell":[57],"response":[58,715],"tumor":[60],"post-transplant.":[62],"AZA":[63,85,131,135],"has":[64],"also":[65],"been":[66,107],"accelerate":[69],"Treg":[70],"reconstitution":[71],"in":[72,77,92,205,266,311,422,441,507,516,546,655,694,721],"murine":[73],"transplant":[74,314],"models,":[75],"resulting":[76],"reduced":[78],"risk":[79,688],"graft-versus-host":[81],"disease":[82,465,690],"(GvHD).":[83],"Thus,":[84],"maintenance":[86,165,618,683,707],"therapy":[87,684],"could":[88],"improve":[89],"outcomes":[91],"MDS":[95,177,300,390],"through":[96],"epigenetic":[97,710],"manipulation":[98,711],"allo-immune":[101],"response.":[102],"Encouraging":[103],"preliminary":[104],"data":[105,675],"have":[106,222],"reported":[108],"subcutaneous":[110],"(SC)":[111],"AZA,":[112],"although":[113],"challenges":[114],"exposure":[116,136],"compliance":[118],"limitations":[120],"SC":[122],"administration.":[123],"CC-486":[124,164,211,229,262,335,429,443,481,617,640,662,706],"novel":[127],"oral":[128],"formulation":[129],"that":[132,681,705],"allows":[133],"prolonged":[134],"extended":[138],"dosing":[139,448,511,520,525,551,611,641,659,666],"schedules":[140,244,254],"sustained":[142],"hypomethylation":[144],"over":[145],"course":[147],"Tx":[150,166,212,230,268,270,373,453,482,619],"cycle.":[151,483],"We":[152],"investigated":[153],"optimal":[155],"dose":[156,329],"schedule,":[158],"tolerability,":[159],"clinical":[161,352],"activity":[162,353],"allo-SCT.":[168,237],"Methods:":[170],"Pts":[171,201],"who":[172,188,380],"had":[173,189,223,318,398,578],"received":[174],"or":[178,183,192,389,417,463,629,692,699,776,824,842],"AML,":[179],"myeloablative":[181],"(MAC)":[182],"reduced-intensity":[184],"(RIC)":[185],"conditioning":[186],"sibling":[191],"unrelated":[193],"donor":[194],"\u22641":[196],"HLA":[197],"mismatch,":[198],"were":[199,202,263,310,502,553,562,592,601,643,652],"eligible.":[200],"be":[204],"morphological":[206],"complete":[207],"remission":[208],"(CR)":[209],"at":[210,313],"initiation":[213],"(ie,":[214],"\u22645%":[215],"bone":[216],"marrow":[217],"[BM]":[218],"blasts)":[219],"must":[221],"ANC":[224],"\u22651.0x109/L":[225],"platelets":[227],"\u226525x109/L.":[228],"begin":[233],"42-84":[234],"days":[235],"In":[238,522],"dose-finding":[240],"phase,":[241],"two":[242,252],"7-day":[243,510,548],"(200":[245,255],"mg":[246,249,256,259,337,445,664],"300":[248],"QD)":[250,260],"14-day":[253,339,447,519,524,550,658,665],"150":[258],"evaluated,":[264],"each":[265,408],"28-day":[267],"cycles.":[269,276,454],"continue":[273],"12":[275,372,452],"Results:":[278],"Of":[279],"31":[280],"pts":[281,298,303,309,346,361,368,378,439,459,492,506,568,584,695],"enrolled,":[282],"pt":[284,317,407,577],"did":[285,384,606],"not":[286,331,530,607,653],"receive":[287],"CC-486;":[288],"thus,":[289],"evaluable":[291],"cohort":[292,340,449,512],"comprised":[293],"30":[294,458],"pts,":[295],"including":[296,476],"4":[297,580],"26":[302],"(Table":[306,613],"1).":[307],"Twenty-nine":[308],"CR":[312],"~8%":[319],"BM":[320],"blasts":[321],"on":[322,770,818,836],"day":[323],"transplant.":[325],"maximum":[327],"tolerated":[328],"reached.":[332],"Consequently,":[333],"200":[336,444,663],"QD":[338,446],"expanded":[342],"include":[344],"additional":[345],"further":[348,672],"assessment":[349],"this":[355],"regimen.":[356],"Median":[357,484],"follow-up":[358],"all":[360,371,451,491],"19.0":[363],"months":[364,495],"(range":[365,434],"1.0-41.3).":[366],"Thirteen":[367],"(43%)":[369],"completed":[370,450],"cycles;":[374],"17":[377],"(57%)":[379],"discontinued,":[381],"6":[382],"(20%)":[383],"so":[385],"due":[386,410],"relapse,":[391],"5":[392],"(17%)":[393],"withdrew":[394],"consent,":[395],"3":[396,477,572],"(10%)":[397,569],"non-GvHD":[400],"Tx-emergent":[401],"adverse":[402],"event":[403],"(TEAE),":[404],"discontinued":[409],"death,":[412],"development":[413],"chronic":[415,586,630],"GvHD,":[416,631],"recurrence":[418],"involvement":[421],"CNS.":[424],"median":[426,527,538,634,648],"number":[427],"cycles":[430],"delivered":[431],"9":[433],"1-12).":[435],"Ten":[436],"19":[438],"(53%)":[440],"Eight":[456,583],"(27%)":[460],"experienced":[461,570,585],"progressive":[464],"(PD);":[466],"7":[467],"occurred":[469],"study":[474],"entry,":[475],"first":[480],"relapse-":[485],"progression-free":[487],"survival":[488,544],"(RPFS)":[489],"34.1":[494],"(95%CI":[496,540],"15.3,":[497],"37.8).":[498],"Rates":[499],"relapse/PD":[501],"57%":[503],"(4/7)":[504],"combined":[509,518,657],"17%":[514],"(4/23)":[515],"group.":[521],"cohorts,":[526],"RPFS":[528,560,635,651],"reached":[531,654],"(NR;":[532],"95%CI":[533],"10.2,":[534],"NR),":[535],"nor":[536],"OS":[539,649],"15.1,":[541],"NR).":[542],"One-year":[543],"rates":[545,561,624],"cohorts":[552],"86%":[554],"81%,":[556],"respectively,":[557],"1-year":[559],"54%":[563],"72%.":[565],"Three":[567],"grade":[571,579,598],"acute":[573,581,628],"GvHD":[574,587],"no":[576],"GvHD.":[582],"but":[588],"only":[589],"2":[590],"cases":[591],"considered":[593],"severe.":[594],"most":[596],"common":[597],"3-4":[599],"TEAEs":[600],"gastrointestinal":[602],"hematological":[604],"proportionately":[609],"among":[610],"regimens":[612,642],"2).":[614],"Conclusions:":[616],"associated":[621],"low":[623],"~3":[637],"years.":[638],"Extended":[639],"generally":[644],"well":[645],"tolerated,":[646],"cohort.":[660],"regimen":[667],"will":[668],"move":[669],"forward":[670],"study.":[673],"Our":[674],"consistent":[677],"hypothesis":[680,704],"may":[685,708],"reduce":[686],"progression":[693],"allografted":[696],"MDS,":[700],"support":[702],"permit":[709],"alloreactive":[714],"post-allograft.":[716],"These":[717],"findings":[718],"require":[719],"confirmation":[720],"prospective":[722],"randomized":[723],"trials.":[724],"Download":[734,737,747,750],":":[735,748],"high-res":[738],"image":[739,752],"(292KB)":[740],"full-size":[751],"Disclosures":[764],"de":[766],"Lima:":[767],"Pfizer:":[768],"Membership":[769,817,835],"an":[771,819,837],"entity's":[772,820,838],"Board":[773,821,839],"Directors":[775,823,841],"advisory":[777,825,843],"committees;":[778],"Celgene":[779,850,856,862],"Corporation:":[780,851,857,863],"Research":[781,785,788,791,811,827],"Funding.":[782,792],"Oran:":[783],"Celgene:":[784,815],"Funding;":[786,789],"AROG:":[787],"Astex:":[790],"Scott:":[793],"Acceleron:":[794],"Other:":[795],"Data":[796],"Safety":[798],"Monitoring":[799],"Board;":[800],"Incyte:":[801],"Honoraria,":[802,807,816,834],"Speakers":[803,808,813,829],"Bureau;":[804,809,814,830],"Alexion:":[805],"Consultancy,":[806,847],"Novartis:":[810],"Funding,":[812,828],"committees,":[826],"Agios":[831],"Pharmaceuticals,":[832],"Inc.:":[833],"committees.":[844],"William:":[845],"Miragen:":[846],"Honoraria.":[848],"Hetzer:":[849],"Employment,":[852,858,864],"Equity":[853,859,865],"Ownership.":[854,860,866],"Hubbell:":[855],"Skikne:":[861]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2019-05-29T00:00:00"}